Beacon Capital Management LLC (Tennessee)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20
Closed -$1.87K 1064
2023
Q4
$1.87K Hold
20
﹤0.01% 804
2023
Q3
$1.83K Hold
20
﹤0.01% 856
2023
Q2
$1.83K Hold
20
﹤0.01% 856
2023
Q1
$1.47K Hold
20
﹤0.01% 795
2022
Q4
$1.67K Buy
+20
New +$1.8K ﹤0.01% 826

Other funds holding AMED

Beacon Capital Management LLC (Tennessee)'s AMED Position: Q1 2024 in Review

Beacon Capital Management LLC (Tennessee) sold out of Amedisys (AMED) in Q1 2024, closing a stake of 20 shares — an estimated $1.87K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in AMED in Q4 2022 and held it in 5 quarters. The position peaked at $1.87K in Q4 2023. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Amedisys position as of Q1 2024 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 20 Amedisys shares in Q1 2024, an estimated $1.87K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Amedisys in Q4 2022 and held it in 5 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Amedisys position peaked at $1.87K in Q4 2023.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q1 2024, filed 16 May 2024.